BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:RC28-E readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of RC28-E\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07936487-5061@assetmemo.bio
DTSTAMP:20261121T004446Z
DTSTART;VALUE=DATE:20281201
DTEND;VALUE=DATE:20281202
SUMMARY:RC28-E: Phase 3 readout est. (NCT07936487)
DESCRIPTION:RC28-E\, phase 3\, Diabetic Macular Edema.\nStudy: IIIb Trial f
 or RC28-E Injection in Participants With DME and wAMD\nEstimated primary c
 ompletion: 1 December 2028. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/rc28-e#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT07936487
URL:https://assetmemo.bio/drug/rc28-e#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
